To characterize commercial opportunities, we typically start by listing all possible indications for a product and develop a high-level prioritization.
These assessments typically include a clear description and sizing of the target patient population, current market size and dynamics, identification of key medical and payer constituents, current medical practice and treatments, disease burden and unmet medical need, current and future drug and non-drug competition, pricing potential and value arguments, launch and patent expiry dates.
Develop adaptive, flexible comprehensive forecast (epidemiological/patient or prescription-based models) in a user-friendly Excel format allowing sensitivity analysis around key variables impacting the forecast.
We provide budget estimates to launch and sell the drug (i.e. marketing, medical affairs, commercial data infrastructure, supply chain, patient services, and sales).